Columbia City, IN, United States of America

David Alan Detwiler

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):

Title: David Alan Detwiler: Innovator in Microbial Inactivation

Introduction

David Alan Detwiler is an accomplished inventor based in Columbia City, IN (US). He holds a total of 3 patents that focus on innovative methods for inactivating bacteria using electric pulses and antibiotics. His work has significant implications for microbial control and antibiotic efficacy.

Latest Patents

One of Detwiler's latest patents involves a method for reducing the number of viable microbes. This method includes contacting microbes with an antibiotic compound and applying pulses of electricity with a duration ranging from about 50 nanoseconds to about 900 nanoseconds. The intensity of these electric pulses can vary between about 20 kV/cm and about 40 kV/cm, and they may be applied at a frequency of between about 0.1 Hz and about 10 Hz. The microbes targeted can be either gram-negative or gram-positive strains of bacteria. Notably, the antibiotic is applied at a concentration and duration that does not significantly reduce the viable number of bacteria unless the electric pulses are also applied.

Career Highlights

Throughout his career, Detwiler has contributed to various research initiatives. He has worked with the Purdue Research Foundation and Nanovis, LLC, where he has been instrumental in advancing research in microbial inactivation technologies.

Collaborations

Detwiler has collaborated with notable individuals in his field, including Allen Lawrence Garner and Ram Anand Vadlamani. Their combined expertise has furthered the development of innovative solutions in microbial control.

Conclusion

David Alan Detwiler's contributions to the field of microbial inactivation through his patented methods highlight his role as a significant innovator. His work continues to influence the effectiveness of antibiotics and the management of bacterial strains.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…